Treatment of Neuromyelitis Optica: Review and Recommendations.
Neuromyelitis optica (NMO) is an autoimmune demyelinating disease preferentially targeting the optic nerves and spinal cord. Once regarded as a variant of multiple sclerosis (MS), NMO is now recognized to be a different disease with unique pathology and immunopathogenesis that does not respond to tr...
Main Authors: | Kimbrough, D, Fujihara, K, Jacob, A, Lana-Peixoto, M, Leite, M, Levy, M, Marignier, R, Nakashima, I, Palace, J, de Seze, J, Stuve, O, Tenembaum, SN, Traboulsee, A, Waubant, E, Weinshenker, BG, Wingerchuk, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2012
|
Similar Items
-
Treatment of neuromyelitis optica: Review and recommendations
by: Kimbrough, D, et al.
Published: (2012) -
Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.
by: Pittock, S, et al.
Published: (2019) -
Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
by: Collongues, N, et al.
Published: (2013) -
Neuroimmunology: towards more-accurate diagnosis in neuromyelitis optica.
by: Fujihara, K, et al.
Published: (2014) -
Use of mitoxantrone in neuromyelitis optica.
by: Kitley, J, et al.
Published: (2011)